Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The standard approach involves 250 to 500 micrograms per day via subcutaneous injection, with peri-lesional injection as an option for superficially accessible injuries such as Achilles tendinopathy or lateral epicondylitis
Clinical studies show no significant side effects with long-term daily use
As of early 2026, retatrutide is in Phase 3 clinical trials (the TRIUMPH program)
CPP-CAND disrupts FOXO4-p53 foci and induces apoptosis through caspase-dependent pathways FOXO4 is progressively recruited to euchromatin foci following senescence induction and is retained in the nucleus of senescent cells through its interaction with p53, contributing to the maintenance of the senescent state 34
US$ 27.59
US$ 26.33
US$ 20.97
US$ 28.45
US$ 23.94
US$ 21.79
